Nephrotic syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
Risk factors of nephrotic syndrome depend on the type of syndromes as below: | Risk factors of nephrotic syndrome depend on the type of syndromes as below: | ||
Common risk factors | === Common risk factors === | ||
Risk factors of development of minimal change disease include:<ref name="IijimaHamahira20022">{{cite journal|last1=Iijima|first1=Kazumoto|last2=Hamahira|first2=Kiyoshi|last3=Tanaka|first3=Ryojiro|last4=Kobayashi|first4=Akiko|last5=Nozu|first5=Kandai|last6=Nakamura|first6=Hajime|last7=Yoshikawa|first7=Norishige|title=Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome|journal=Kidney International|volume=61|issue=5|year=2002|pages=1801–1805|issn=00852538|doi=10.1046/j.1523-1755.2002.00303.x}}</ref> | |||
* Children within the Age >1 year but <8 years | * Children within the Age >1 year but <8 years | ||
* Hodgkin lymphoma | * [[Hodgkin's lymphoma|Hodgkin lymphoma]] | ||
* Leukemia | * [[Leukemia]] | ||
* Recent viral illness | * Recent viral illness | ||
* Toxins such as mercury, bee stings, fire coral exposure are one of the causes for minimal change disease. | * Toxins such as mercury, gold bee stings, fire coral exposure are one of the causes for minimal change disease. | ||
* Medication such as<ref name="pmid279404603">{{cite journal |vauthors=Vivarelli M, Massella L, Ruggiero B, Emma F |title=Minimal Change Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=2 |pages=332–345 |date=February 2017 |pmid=27940460 |pmc=5293332 |doi=10.2215/CJN.05000516 |url=}}</ref> | * Medication such as<ref name="pmid279404603">{{cite journal |vauthors=Vivarelli M, Massella L, Ruggiero B, Emma F |title=Minimal Change Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=2 |pages=332–345 |date=February 2017 |pmid=27940460 |pmc=5293332 |doi=10.2215/CJN.05000516 |url=}}</ref> | ||
**Salazopyrin | **Salazopyrin | ||
**Tiopronin | |||
** Tiopronin | |||
** Lithium | ** Lithium | ||
** D-penicillamine | ** D-penicillamine | ||
** Tyrosine-kinase inhibitor | ** Tyrosine-kinase inhibitor | ||
The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):<ref name="FSGS">{{cite web |url= http://cdn.intechopen.com/pdfs/22820/InTech-Focal_segmental_glomerulosclerosis.pdf|title= Focal segmental glomerulosclerosis.|last1= Sohal |first1= DS |last2= Prabhakar |first2= SS |date=November 02, 2011|website= Interchopen |publisher= InTech |accessdate=3 December 2013}}</ref> | The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):<ref name="FSGS">{{cite web |url= http://cdn.intechopen.com/pdfs/22820/InTech-Focal_segmental_glomerulosclerosis.pdf|title= Focal segmental glomerulosclerosis.|last1= Sohal |first1= DS |last2= Prabhakar |first2= SS |date=November 02, 2011|website= Interchopen |publisher= InTech |accessdate=3 December 2013}}</ref> | ||
| Line 39: | Line 36: | ||
* Obesity | * Obesity | ||
=== Less common risk factors === | |||
Below conditions and toxins can be a risk factor for nephrotic syndrome<ref name="pmid12944064">{{cite journal| author=Eddy AA, Symons JM| title=Nephrotic syndrome in childhood. | journal=Lancet | year= 2003 | volume= 362 | issue= 9384 | pages= 629-39 | pmid=12944064 | doi=10.1016/S0140-6736(03)14184-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12944064 }}</ref> | |||
*Adaptation to [[nephron]] reduction | |||
*[[Amyloidosis]] | |||
*[[Bee sting]] | |||
*[[Castleman's disease]] | |||
*[[Chronic interstitial nephritis]] | |||
*[[Dermatomyositis]] | |||
*[[Diabetes mellitus]] | |||
*[[Endocarditis]] | |||
*[[Fabry's disease]] | |||
*[[Food allergens]] | |||
*[[Gold]] | |||
*[[Goodpasture's syndrome]] | |||
*[[Graft vs. host disease]] | |||
*[[Henoch-Schonlein purpura]] | |||
*[[Heroin]] | |||
*[[HIV]] | |||
*[[Infectious mononucleosis]] | |||
*[[Interferon]] | |||
*[[Kimura's disease]] | |||
*[[Leukemia]] | |||
*[[Lipoatrophy]] | |||
*[[Lithium]] | |||
*[[Lymphomas]] | |||
*[[Malaria]] | |||
*[[Mercury]] | |||
*[[Mixed connective tissue disease]] | |||
*[[Multiple myeloma]] | |||
*[[NSAID]] | |||
*[[Obesity]] | |||
*Oligomeganephronia | |||
*[[Orthostatic proteinuria]] | |||
*[[Penicillamine]] | |||
*[[Polyarteritis nodosa]] | |||
*[[Pre-eclampsia]] | |||
*[[Probenecid]] | |||
*[[Renal vein thrombosis]] | |||
*[[Rheumatoid arthritis]] | |||
*[[Sarcoidosis]] | |||
*[[Sickle cell anemia]] | |||
*[[Sjogren's syndrome]] | |||
*[[Sorafenib]] | |||
*[[Streptococcal Infection]] | |||
*[[Syphillis]] | |||
*[[Systemic lupus erythematosus]] | |||
*[[Thyroid disease]] | |||
*[[Toxoplasmosis]] | |||
*[[Vasculitis]] | |||
*[[Viral hepatitis]] | |||
====Drug Induced==== | |||
*[[Agalsidase beta]] | |||
*[[Certolizumab pegol]] | |||
*[[coagulation factor IX]] | |||
*[[Olsalazine]] | |||
*[[Sodium aurothiomalate]] | |||
*[[Trimethadione]] | |||
*[[Ziv-aflibercept]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:16, 16 May 2018
|
Nephrotic Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nephrotic syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Nephrotic syndrome risk factors |
|
Risk calculators and risk factors for Nephrotic syndrome risk factors |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
|
Nephrotic Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nephrotic syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Nephrotic syndrome risk factors |
|
Risk calculators and risk factors for Nephrotic syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, Serge Korjian
Overview
Risk factors
Risk factors of nephrotic syndrome depend on the type of syndromes as below:
Common risk factors
Risk factors of development of minimal change disease include:[1]
- Children within the Age >1 year but <8 years
- Hodgkin lymphoma
- Leukemia
- Recent viral illness
- Toxins such as mercury, gold bee stings, fire coral exposure are one of the causes for minimal change disease.
- Medication such as[2]
- Salazopyrin
- Tiopronin
- Lithium
- D-penicillamine
- Tyrosine-kinase inhibitor
The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):[3]
- Male gender
- Black race
- Family history
- Heroin abuse
- Drugs known to be associated with FSGS
- Chronic viral infection
- Solitary kidney
- Obesity
Less common risk factors
Below conditions and toxins can be a risk factor for nephrotic syndrome[4]
- Adaptation to nephron reduction
- Amyloidosis
- Bee sting
- Castleman's disease
- Chronic interstitial nephritis
- Dermatomyositis
- Diabetes mellitus
- Endocarditis
- Fabry's disease
- Food allergens
- Gold
- Goodpasture's syndrome
- Graft vs. host disease
- Henoch-Schonlein purpura
- Heroin
- HIV
- Infectious mononucleosis
- Interferon
- Kimura's disease
- Leukemia
- Lipoatrophy
- Lithium
- Lymphomas
- Malaria
- Mercury
- Mixed connective tissue disease
- Multiple myeloma
- NSAID
- Obesity
- Oligomeganephronia
- Orthostatic proteinuria
- Penicillamine
- Polyarteritis nodosa
- Pre-eclampsia
- Probenecid
- Renal vein thrombosis
- Rheumatoid arthritis
- Sarcoidosis
- Sickle cell anemia
- Sjogren's syndrome
- Sorafenib
- Streptococcal Infection
- Syphillis
- Systemic lupus erythematosus
- Thyroid disease
- Toxoplasmosis
- Vasculitis
- Viral hepatitis
Drug Induced
- Agalsidase beta
- Certolizumab pegol
- coagulation factor IX
- Olsalazine
- Sodium aurothiomalate
- Trimethadione
- Ziv-aflibercept
References
- ↑ Iijima, Kazumoto; Hamahira, Kiyoshi; Tanaka, Ryojiro; Kobayashi, Akiko; Nozu, Kandai; Nakamura, Hajime; Yoshikawa, Norishige (2002). "Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome". Kidney International. 61 (5): 1801–1805. doi:10.1046/j.1523-1755.2002.00303.x. ISSN 0085-2538.
- ↑ Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). "Minimal Change Disease". Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMC 5293332. PMID 27940460.
- ↑ Sohal, DS; Prabhakar, SS (November 02, 2011). "Focal segmental glomerulosclerosis" (PDF). Interchopen. InTech. Retrieved 3 December 2013. Check date values in:
|date=(help) - ↑ Eddy AA, Symons JM (2003). "Nephrotic syndrome in childhood". Lancet. 362 (9384): 629–39. doi:10.1016/S0140-6736(03)14184-0. PMID 12944064.